We identified all patients of working age (18-60 years) with a first HF hospitalization in the period 1997-2015 in Denmark, categorized according to whether or not they were part of the workforce at time of the index admission. The primary outcome was death from any cause and the secondary outcome was readmission for HF. Cumulative incidence curves, binomial regression and Cox regression models were used to assess outcomes. Of 25 571 patients with a first hospitalization for HF, 15 428 (60%) were part of the workforce at baseline. Patients in the workforce were significantly younger (53 vs. 55 years) more likely to be male (75% vs 64%) and less likely to have diabetes (13% vs 22%) and chronic obstructive pulmonary disease (5% vs 10%) (all P < 0.0001). Not being part of the workforce was associated with a significantly higher risk of death [hazard ratio (HR) 1.59; 95% confidence interval (CI) 1.50-1.68] and rehospitalization for HF (HR 1.09; 95% CI 1.05-1.14), in analyses adjusted for age, sex, co-morbidities, education level, calendar time, and duration of first HF hospitalization.
Introduction
Heart failure (HF) is a common and costly disease associated with high risk of hospitalization and death.
1 -4 Despite advances in treatment, HF is still associated with a reduced quality of life, and a prognosis comparable with some types of cancer. 5 The ability to work provides valuable information on patients' well-being and performance status. It might also have an impact on subsequent disease trajectory as employment status might be associated with better uptake of cardiac rehabilitation and adherence to evidence-based therapy. In contrast, detachment from the workforce has been associated with increased risk of depression, mental health problems and even suicide. 6 -8 Several parameters have been identified as independent predictors of morbidity and mortality in HF, including age, sex, ejection fraction, diabetes, renal function, and New York Heart Association (NYHA) functional class. 9, 10 Employment status could be a relevant additional predictive factor in younger patients with HF, but its importance for prognosis is unclear.
11 -14 We hypothesized that employment status is correlated with prognosis in terms of morbidity and mortality for patients with HF. Information about the relationship between employment status and morbidity and mortality could help risk stratify younger HF patients and identify individuals who might benefit from more intensive rehabilitation. Therefore, we examined the association between employment status and the risk of death from any cause and recurrent HF hospitalization in a nationwide cohort of HF patients.
Methods

Data sources
Nationwide administrative registries were linked by use of unique personal identification numbers assigned to all Danish residents. 15 We were able to collect information on hospitalizations, prescribed medications, education level, public welfare payments, and vital status on an individual level. 16, 17 
Study population and baseline variables
Patients aged 18-60 years at time of first HF hospitalization in the period 1997-2015 were included in the study (supplementary material online, Appendix S1). Employment status was determined during the 5 weeks prior to first hospitalization for HF. Patients who received public support due to reduced working capability in 3 or more of the 5 evaluated weeks were classified as detached from the workforce, as done previously. 18 Thus, patients in the workforce also included patients who were unemployed. The evaluation period of 5 weeks was chosen so as not to include patients on short-term sick leave and misclassify them as detached from the workforce. The following co-morbidities were identified by discharge diagnoses during a 10-year period before first hospitalization with HF: ischaemic heart disease, cancer, atrial fibrillation, chronic kidney disease, chronic obstructive pulmonary disease (COPD), diabetes mellitus, hypertension, and stroke. Filled prescriptions for glucose-lowering drugs 6 months prior to first HF hospitalization were used to identify additional patients with diabetes. Procedures for implantation of cardiac devices were identified and prior surgical procedures in the form of valve surgery and coronary artery bypass grafting were classified according to NOMESCO Classification of Surgical Procedures. 19 Diagnosis and procedure codes are listed in the Supplementary Appendix S1 online. Baseline use of pharmacotherapy was defined by one or more filled in prescriptions 6 months prior to first HF hospitalization. Use of the following drugs was assessed: angiotensin-converting enzyme inhibitors (ACE-I) or angiotensin II receptor blockers (ARB), aspirin, calcium channel blockers, digoxin, clopidogrel, mineralocorticoid receptor antagonists (MRAs), statins, -blockers, loop diuretics, antidepressants, and antipsychotics. We did not account for treatment initiated during the index hospitalization for HF. Income was calculated as 5-year average family income prior to first HF hospitalization and further classified into quartiles.
Outcome measures
Our primary outcome was death from any cause. Recurrent hospitalization for HF was evaluated as the secondary outcome. In a sensitivity analysis we further categorized patients not in the workforce at baseline according to whether their employment status 1 year before first HF hospitalization and examined the association with mortality and recurrent HF hospitalization. We also tentatively adjusted for prior outpatient clinic visit for HF. Furthermore, we repeated Cox regression analyses on death including HF medication and cardiac devices.
Statistics
Differences in baseline characteristics among patients in and out of the workforce were tested using Wilcoxon test for continuous variables and 2 test for categorical variables. Cumulative incidence curves were estimated for death and rehospitalization for HF, respectively. In analyses of rehospitalization, death was treated as a competing risk. Cumulative incidence curves were estimated using the Aalen-Johansen method. 20 Unadjusted differences were evaluated using Gray's test. Hazard ratios (HRs) for death and rehospitalization were calculated using cause-specific Cox regression models. Cox regression analyses were adjusted for age, sex, level of education, calendar time, length of first HF hospitalization, antidepressants, antipsychotics, and co-morbidities (i.e. ischaemic heart disease, atrial fibrillation, chronic kidney disease, COPD, diabetes, hypertension, stroke, and cancer). All factors were included in each of the presented adjusted models. Log [−log(survival)] curves was used to evaluate the proportional hazard assumption. Interactions between age, sex, co-morbidities and employment status were tested for both outcomes and none were found to be significant. The rate of total hospitalizations for HF was compared using negative binomial regression with logarithm of the duration of follow-up as the offset. 21 Data management and statistical analyses were performed using SAS statistical software package, version 9.4 (SAS Institute, Cary, NC, USA) and R, version 3.3.2 (R development Core Team).
Results
Baseline characteristics of the study population
We identified 25 571 patients with a first hospitalization for HF in the period 1997-2015. Of these, 15 428 individuals (60%) were part of the workforce at baseline. Patients in the workforce were significantly younger (median age 53 years vs. 55 years), more were men (75% vs. 64%) and they had a higher level of education (17% vs. 10%; Table 1 ). All co-morbidities were less prevalent among patients in the workforce group. Patients in the workforce were more often treated with -blockers (56% vs. 51%) and ACE-I/ARB (66% vs. 63%) but were less likely to be on loop diuretics (49% vs. 61%) and MRAs (21% vs. 26%).
Mortality
The median follow-up was 781 days (Q1-Q3 105-1825 days). During this period, 2205 patients (14%) died in the workforce group and 3213 patients (32%) in the non-workforce group [risk of death 14% (13-16%) vs. 32% (31-33%); P < 0.0001; Figure 1 ]. The unadjusted HR for all-cause mortality was 2.15 [95% confidence interval (CI) 2.03-2.27] for patients out of the workforce compared to patients in the workforce. In adjusted analyses, HF patients not part of the workforce at baseline remained at higher risk of death (HR 1.59, 95% CI 1.50-1.68; P < 0.0001; Figure 2 Figure 1 Risk of death among patients in and out of the workforce at time of first heart failure hospitalization (n = 25 571).
In a sensitivity analysis, patients who were not in the workforce at baseline nor at 1 year before hospitalization (n = 7718) had an HR for death of 1.66 (95% CI 1.56-1.77), compared with those in the workforce at baseline. Patients with recent detachment from the workforce (<1 year) had an HR for death of 1.38 (95% CI 1.25-1.51) compared with patients in the workforce at baseline. There was a significant interaction between length of detachment (≥1 year vs. <1 year) and employment status in relation to mortality (P < 0.0001). In total, 3637 (14%) of the patients were seen in an outpatient clinic prior to first HF hospitalization; adding this information to the main analyses did not change the results. In a Cox regression analysis including cardiovascular medications and cardiac devices, HF patients not part of the workforce at baseline still had a higher risk of death. ARB, -blockers and implantable cardioverter defibrillators were associated with lower likelihood of death. Conversely, loop diuretics and MRAs were associated with higher likelihood of death (supplementary material online, Figure S1 ).
Rehospitalization for heart failure
During follow-up, 6495 (42%) in the workforce group and 4739 (47%) in the non-workforce group were rehospitalized for HF [5-year risk of rehospitalization for HF 45% (44-46%) vs. 47% (46-48%); P = 0.03; Figure 3 ]. In Cox regression analyses, this yielded an unadjusted HR of 1.09 (1.05-1.13; P = 0.0005) and an adjusted HR of 1.09 (1.05-1.14; P < 0.0001), respectively. Other factors associated with rehospitalization for HF included younger age, male sex, use of antidepressants, COPD, diabetes, and cancer ( Figure 4) . In adjusted analyses the HR for HF rehospitalization during the first year after discharge from first HF hospitalization was 1.05 (95% CI 1.01-1.10; P = 0.04), whereas the HR for HF rehospitalization from 1 to 5 years after first HF hospitalization was 1.20 (95% CI 1.11-1.29; P < 0.0001). 
Discussion
The present study examined the association between employment status and the risk of death and recurrent HF hospitalization in a nationwide cohort of 25 571 HF patients. The main result of the study was that HF patients not in the workforce had a significant higher adjusted risk of death, and recurrent hospitalization for HF, although not as pronounced. This excess risk of death in patients not in the workforce was comparable to that associated with co-morbidities such as diabetes or prior stroke. Several prognostic factors for patients with HF have been identified and included in risk scores. 9,10,22 -24 However, none of these models has included variables assessing functional performance in the community such as employment status. Evidently, employment status is only relevant in HF patients of working age, but in this subgroup of patients, it may be valuable when quantifying the overall prognosis of young HF patients. The exact mechanism of how employment status is related to mortality and recurrent HF hospitalization is complex and most likely multi-factorial. The ability to work can be seen as a measure of good performance status and may reflect that patients are able to meet the physical requirements of a full-time job. As performance status is closely associated with morbidity and mortality in HF, this could, at least in part, explain the association we found. However, employment status is more than just another physical measurement as it also influences patients' quality of life and has been shown to be important for mental health and well-being. 6, 8 Quality of life is also associated with outcome in HF. There may be other more Figure 2 Results from multivariable Cox regression model of factors associated with death among patients in and out of the workforce at time of first heart failure hospitalization (n = 25 571), adjusted for age, sex, level of education, calendar time, length of first heart failure hospitalization, use of antidepressants, use of antipsychotics, and co-morbidities [i.e. ischaemic heart disease, atrial fibrillation, chronic kidney disease, chronic obstructive pulmonary disease (COPD), hypertension, stroke, and cancer].
indirect mechanisms through which employment status influences outcome. For example, loss of income could lead to poorer nutrition and, through loss of self-esteem, adoption of unhealthy habits such as excessive alcohol consumption or resumption of smoking. Similarly, hopelessness or despair might reduce adherence to medical therapy and a healthy lifestyle. Thus, both from a physical and psychological perspective, it makes sense to include employment status as part of the evaluation of young patients with HF. While it may not be surprising that employment status is related to prognosis, the strength of the association is unexpected. Employment status was associated with a risk of death comparable with that of co-morbidities such as diabetes and stroke. 9, 25 For different reasons, patients out of the workforce are not able to be part of the workforce. These reasons are likely to be associated with a higher likelihood of death. We adjusted our analyses for some of the reasons, i. chronic kidney disease, COPD, diabetes, stroke, and cancer. But after adjusting for these factors, known to be associated with worse prognosis, the association of employment status and death is still highly significant. It is highly likely that not being part of the workforce captures some otherwise unmeasured covariates that influence prognosis in this population. Socio-economic characteristics have been shown to be related to the use of evidence-based medication and cardiac devices. 26 Thus, employment status might also have impact on use of medication and cardiac devices, which in return could mediate some of the effect on mortality and rehospitalization related to employment status. Thus, further knowledge on which elements workforce exclusion covers could be valuable and might be target for intervention. 27 Thus, so far, employment status is an interesting and valuable factor to assess.
The main strength of this study is the use of nationwide registries with complete unselected information on all patients admitted to a hospital with HF as a discharge diagnosis. These registries made it possible for us to link weekly updated data on occupational status with data on hospitalization, medication and vital status on a nationwide scale. We chose to look at workforce availability instead of employment, and thus our results are not affected by any fluctuations in the employment opportunities. The main limitation of the study is missing information on clinically important variables, especially ejection fraction and NYHA class status. It is highly likely that not being part of the workforce captures some otherwise unmeasured covariates that affect prognosis in this population, and caution should be used when interpreting the finding that employment status is an independent predictor of mortality and . rehospitalization among HF patients. The observational nature of the study means that the effect of unmeasured confounders cannot be excluded and that our findings reflect associations and not causal connections.
Workforce detachment at time of first HF hospitalization was associated with a higher subsequent risk of death and rehospitalization for HF. Patients outside the workforce had a risk of death comparable to that of patients with diabetes or stroke. Employment status could be a valuable factor in the evaluation of young HF patients' prognosis and a possible target for intervention.
Figure 4
Results from one multivariable cause specific Cox regression model of factors associated with rehospitalization for heart failure among patients in and out of the workforce (n = 25 571), adjusted for age, sex, level of education, calendar time, length of first heart failure hospitalization, use of antidepressants, use of antipsychotics, and co-morbidities [i.e. ischaemic heart disease, atrial fibrillation, chronic kidney disease, chronic obstructive pulmonary disease (COPD), hypertension, stroke, and cancer].
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